MAX BioPharma and Metaba Announce Collaboration on Metabolomics Studies :...
MAX Pharma Inc. Announces Collaboration with Metaba, LLC to Study Metabolomics as They Develop Novel Oxysterol Drug Candidates
read more
News and Events
MAX BioPharma Will Be Attending the Biocom Global Partnering & Investor Conference
MAX BioPharma will be attending Biocom’s Global Life Science Partnering & Investor conference scheduled for February 27th – February 29th in La...
MAX BioPharma to Attend Biocom’s Global Life Science Partnering & Investor Conference
MAX BioPharma will be attending Biocom's Global Life Science Partnering & Investor conference scheduled for February 28th - March 2nd. The...
Inhibition of Profibrotic Signaling by Oxy210
MAX BioPharma reports on the inhibition of profibrotic signaling in cellular models of lung and kidney fibrosis by its oxysterol drug candidate,...
MAX BioPharma reports on the anti-inflammatory effects of its drug candidate, Oxy210
MAX BioPharma reports on the anti-inflammatory effects of its oxysterol drug candidate, Oxy210, an orally available small moleculedifferent from...